Breaking News Instant updates and real-time market news.

PEN

Penumbra

$148.85

0.85 (0.57%)

16:43
08/07/18
08/07
16:43
08/07/18
16:43

Penumbra reports Q2 EPS 37c, consensus 3c

Reports Q2 revenue $109.6M, consensus $102.2M.

  • 07

    Aug

  • 27

    Aug

PEN Penumbra
$148.85

0.85 (0.57%)

05/09/18
ADAM
05/09/18
NO CHANGE
Target $165
ADAM
Buy
Penumbra price target raised to $165 from $125 at Canaccord
Canaccord analyst Jason Mills raised his price target on Penumbra to $165 from $125 and recommended investors add to current positions. He called Penumbra one of the most productive growth companies in med-tech and said both the Neuro and Peripheral businesses accelerated, helping the company "blow away" consensus Q1 estimates. Mills reiterated his Buy rating on Penumbra shares.
05/09/18
BMOC
05/09/18
NO CHANGE
Target $140
BMOC
Market Perform
Penumbra price target raised to $140 from $115 at BMO Capital
BMO Capital analyst Joanne Wuensch raised her price target on Penumbra to $140 after the company's Q1 results, saying its constant currency revenue growth has accelerated to 36% from mid-20s seen for most of 2017. The analyst notes that it is not yet clear whether the "ischemic stroke market has entered a new, hyperbolic phase of growth or if it reflects uneven dynamics", but will look to verify the trend. Wuensch keeps her Market Perform rating to reflect the current risk-reward on the company.
05/31/18
WELS
05/31/18
NO CHANGE
Target $180
WELS
Outperform
Penumbra price target raised to $180 from $150 at Wells Fargo
Wells Fargo analyst Larry Biegelsen raised his price target for Penumbra to $180 from $150 following "very strong" Q1 results and meeting with the company's management. The analyst believes management is confident in the outlook of the stroke market and expects Penumbra to remain in a leading position given its advanced technology. He reiterates an Outperform rating on the shares.
06/28/18
BOFA
06/28/18
NO CHANGE
Target $150
BOFA
Buy
Street underestimating Penumbra competition, says BofA/Merrill
BofA/Merrill analyst Bob Hopkins notes that over the last few weeks, he has had the opportunity to conduct extensive diligence on the stroke market and on the competitive technologies coming to challenge Penumbra's market-leading aspiration system. His conversations with stroke-focused physicians from around the world suggest that, in the short-term, the Street may be underestimating the 4-5 new competitors coming to market. While Hopkins does not necessarily think numbers are too high and the long-term outlook remains strong, he believes short-term there is "greater uncertainty." The analyst reiterates a Buy rating and $150 price target on the shares.

TODAY'S FREE FLY STORIES

MNI

McClatchy

$6.85

0.05 (0.74%)

16:41
11/20/18
11/20
16:41
11/20/18
16:41
Hot Stocks
Bluestone Financial reports 6.31% stake in McClatchy »

The Reporting Person…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:38
11/20/18
11/20
16:38
11/20/18
16:38
General news
API crude inventories for week of November 16 »

API reports that crude…

ERA

Era Group

$10.82

0.12 (1.12%)

16:33
11/20/18
11/20
16:33
11/20/18
16:33
Hot Stocks
Era Group names Crystal Gordon SVP General Counsel, Chief Administrative Officer »

Era Group announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ECOM

ChannelAdvisor

$10.44

-0.12 (-1.14%)

16:31
11/20/18
11/20
16:31
11/20/18
16:31
Hot Stocks
ChannelAdvisor, Interpark announce new strategic partnership »

ChannelAdvisor announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 27

    Nov

  • 27

    Nov

  • 28

    Nov

  • 29

    Nov

  • 11

    Dec

ABC

AmerisourceBergen

$88.87

-1.99 (-2.19%)

16:30
11/20/18
11/20
16:30
11/20/18
16:30
Syndicate
Breaking Syndicate news story on AmerisourceBergen »

AmerisourceBergen files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Dec

16:30
11/20/18
11/20
16:30
11/20/18
16:30
Options
Preliminary option volume of 24.3M today »

Preliminary option volume…

ADSK

Autodesk

$122.99

-2.76 (-2.19%)

16:27
11/20/18
11/20
16:27
11/20/18
16:27
Hot Stocks
Breaking Hot Stocks news story on Autodesk »

Autodesk up 8% to $133.23…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 26

    Nov

  • 04

    Dec

HOLX

Hologic

$41.29

-0.29 (-0.70%)

16:23
11/20/18
11/20
16:23
11/20/18
16:23
Hot Stocks
Hologic VP Allison Bebo sells 6,500 shares of company stock »

Hologic VP Allison Bebo…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 27

    Nov

  • 30

    Nov

CAL

Caleres

$30.93

-1.165 (-3.63%)

16:23
11/20/18
11/20
16:23
11/20/18
16:23
Earnings
Caleres lowers FY18 adj. EPS view to $2.25-$2.35 from $2.40-$2.50 »

Consensus $2.46. Raises…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

K

Kellogg

$61.72

0.03 (0.05%)

16:22
11/20/18
11/20
16:22
11/20/18
16:22
Hot Stocks
Kellogg CFO acquires 8,190 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

FLR

Fluor

$41.39

-2.26 (-5.18%)

16:20
11/20/18
11/20
16:20
11/20/18
16:20
Hot Stocks
Fluor selected for lithium, boron mine project in Nevada »

Fluor Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

TGT

Target

$69.05

-8.08 (-10.48%)

, BBY

Best Buy

$63.54

1.35 (2.17%)

16:20
11/20/18
11/20
16:20
11/20/18
16:20
OnTheFly
Fly Intel: Wall Street's top stories for Tuesday »

Stocks began the session…

TGT

Target

$69.05

-8.08 (-10.48%)

BBY

Best Buy

$63.54

1.35 (2.17%)

CPB

Campbell Soup

$40.57

2.1 (5.46%)

KLIC

Kulicke & Soffa

$21.25

1.345 (6.76%)

A

Agilent

$67.61

5.04 (8.06%)

LIVN

LivaNova

$98.00

-22.28 (-18.52%)

LB

L Brands

$28.43

-6.105 (-17.68%)

AAPL

Apple

$177.10

-8.7 (-4.68%)

BSX

Boston Scientific

$34.05

-1.24 (-3.51%)

NAVI

Navient

$10.74

-1.255 (-10.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 20

    Nov

  • 20

    Nov

  • 20

    Nov

  • 20

    Nov

  • 20

    Nov

  • 27

    Nov

  • 29

    Nov

  • 04

    Dec

  • 05

    Dec

  • 11

    Dec

  • 03

    Mar

USAT

USA Technologies

$4.96

-0.055 (-1.10%)

16:20
11/20/18
11/20
16:20
11/20/18
16:20
Hot Stocks
USA Technologies provides update on Nasdaq notification of deficiency »

USA Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

16:20
11/20/18
11/20
16:20
11/20/18
16:20
Options
Closing CBOE SPX and VIX Index summary for November 20th »

The CBOE Volatility Index…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GNMK

GenMark

$5.01

(0.00%)

16:19
11/20/18
11/20
16:19
11/20/18
16:19
Syndicate
Breaking Syndicate news story on GenMark »

GenMark files $150M mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 30

    Nov

CAL

Caleres

$30.93

-1.165 (-3.63%)

16:18
11/20/18
11/20
16:18
11/20/18
16:18
Earnings
Caleres reports Q3 adj. EPS 81c, consensus 88c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

RMBL

RumbleON

$5.76

-0.35 (-5.73%)

16:18
11/20/18
11/20
16:18
11/20/18
16:18
Syndicate
Breaking Syndicate news story on RumbleON »

RumbleON files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

  • 10

    Dec

GPS

Gap

$24.65

-0.79 (-3.11%)

16:18
11/20/18
11/20
16:18
11/20/18
16:18
Earnings
Gap narrows FY18 EPS view to $2.55-$2.60 from $2.55-$2.70, consensus $2.56 »

Backs FY18 SSS view of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 03

    Mar

MRCY

Mercury Systems

$46.80

-0.48 (-1.02%)

16:18
11/20/18
11/20
16:18
11/20/18
16:18
Hot Stocks
Mercury Systems gets $6.7M Integrated subsystems order for naval electronics »

Mercury Systems announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRI

Thomson Reuters

$47.83

-0.59 (-1.22%)

16:17
11/20/18
11/20
16:17
11/20/18
16:17
Hot Stocks
Thomson Reuters receives court approval for return of capital transaction »

Thomson Reuters announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

STRM

Streamline Health

$0.90

(0.00%)

, WFC

Wells Fargo

$52.54

-0.77 (-1.44%)

16:17
11/20/18
11/20
16:17
11/20/18
16:17
Hot Stocks
Streamline Health extends banking agreement with Wells Fargo into 2020 »

Streamline Health…

STRM

Streamline Health

$0.90

(0.00%)

WFC

Wells Fargo

$52.54

-0.77 (-1.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Apr

  • 13

    Jul

  • 12

    Oct

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

16:17
11/20/18
11/20
16:17
11/20/18
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPS

Gap

$24.65

-0.79 (-3.11%)

16:16
11/20/18
11/20
16:16
11/20/18
16:16
Earnings
Gap reports Q3 EPS 69c, consensus 68c »

Reports Q3 revenue $4.1B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 03

    Mar

$NYE

NYSE Market Internals

$0.00

(0.00%)

16:16
11/20/18
11/20
16:16
11/20/18
16:16
Technical Analysis
NYSE market internals summary »

Volume was above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FL

Foot Locker

$46.10

-2.69 (-5.51%)

16:14
11/20/18
11/20
16:14
11/20/18
16:14
Hot Stocks
Breaking Hot Stocks news story on Foot Locker »

Foot Locker up 11% to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.